The Satiety Effect After Okara Compared to Porridge Eating
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01075568 |
Recruitment Status : Unknown
Verified February 2010 by Tel-Aviv Sourasky Medical Center.
Recruitment status was: Not yet recruiting
First Posted : February 25, 2010
Last Update Posted : March 3, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Healthy People | Dietary Supplement: Nutrigal Okara - 100 | Not Applicable |
This will be a single blind, cross-over design. Study population will include 10 subjects. The patients will be randomly assigned to receive one of two meals, 48 gram Okara or 40 gram (similar caloric value) semolina in two occasions (two visits). After the eating, the subject will stay in a closed room, without watch or any irritation. After three hours, the patient will fill a VAS questionnaire, and will get a standard meal. The meal will be weighed before and after.
Okara is a natural water extracted food grade soy product, contains approximately 35% protein (mfb), and about 43% of dietary fibers.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 10 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | Single |
Study Start Date : | March 2010 |
Estimated Primary Completion Date : | October 2010 |
Estimated Study Completion Date : | December 2010 |
- To examine the satiety effect after 48 gram Okara compared to 40 gram of porridge eating.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Healthy volunteers
- Age 20-65 years old
- Written Informed Consent
Exclusion Criteria:
- History of gastro-intestinal surgery
- On medication that may influence gastric emptying, or medication for weight loss
- Patient on PPI treatment, H2 Blockers or medication for weight loss
- Known allergies to soy
- Pregnancy or breast-feeding
- Smoking
- Athletes
- Metabolic syndrome or diabetes mellitus
- Family history of metabolic syndrome or diabetes mellitus
- Weight loss > 2 kg during two months before the study

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01075568
Contact: Nachum Vaisman, Prof' | 009-972-3-6974807 | vaisman@tasmc.health.gov.il |
Israel | |
Tel Aviv Medical Center | |
Tel Aviv, Israel | |
Contact: Nachum Vaisman, Prof' 00-972-3-6974807 vaisman@tasmc.health.gov.il |
ClinicalTrials.gov Identifier: | NCT01075568 |
Other Study ID Numbers: |
TASMC-10-NV-016-CTIL |
First Posted: | February 25, 2010 Key Record Dates |
Last Update Posted: | March 3, 2010 |
Last Verified: | February 2010 |